Dr Julien Dreyfus (Centre Cardiologique du Nord, Saint-Denis, FR) joins us to discuss workflow strategies for the transcatheter treatment of tricuspid regurgitation across a broad patient population.

Tricuspid regurgitation remains one of the most undertreated valvular conditions in cardiology, yet the landscape is changing rapidly as transcatheter therapies mature and patient referral pathways develop. With multiple devices now available and a wide spectrum of TR severity, aetiology, and patient complexity to navigate, establishing effective and adaptable workflow strategies has become a priority for heart valve teams.

Interview Questions:

1. Why are things are moving so fast in the TR field
2. When should patients be referred to heart valve centres
3. What is the diagnostic pathway
4. What are the different options currently available

Recorded on-site at EuroPCR 2026, Paris.
Editors: Jordan Rance
Videographer: Dan Brent
Support: This is an independent interview produced by Radcliffe Cardiology.